Active Ingredient (Generic Name) | Letrozole |
---|---|
Indication | Breast Cancer |
Manufacturer | Cipla Ltd. |
Packaging | 10 tablets per strip |
Strength | 2.5MG |
Delivery Time | 8 Days |
Generic Name: Letrozole
Brand Name: Letrozole / Letall 2.5 mg
Strength: 2.5 mg
Manufacturer: Cipla Ltd. (Letrozole) / Intas Pharmaceuticals (Letall)
Form: Tablet
Packaging Size: 3 Strips of 10 Tablets (Total: 30 Tablets)
Packaging Type: Strip
Prescription Required: Yes
Country of Origin: Made in India
Minimum Order Quantity: 10 Strips
Each tablet contains: Letrozole 2.5 mg
Indication: Treatment of breast cancer in postmenopausal women
Specifically used for:
Early-stage hormone receptor-positive breast cancer
Metastatic breast cancer
As adjuvant therapy following surgery or radiation treatment
Letrozole is a non-steroidal aromatase inhibitor that works by reducing estrogen levels in the body, which helps slow or stop the growth of hormone-sensitive breast cancer cells.
Taken orally, once daily, with or without food
Dosage and treatment duration should be determined by a qualified oncologist
Regular monitoring is essential during treatment
Clinically proven efficacy in hormone-receptor-positive breast cancer
Manufactured by leading pharmaceutical companies Cipla and Intas Pharmaceuticals
Convenient strip packaging ensures proper dosing and storage
Suitable for clinical and hospital settings
Cost-effective alternative to international brands
Generic Name: Letrozole
Brand Name: Letrozole / Letall 2.5 mg
Strength: 2.5 mg
Manufacturer: Cipla Ltd. (Letrozole) / Intas Pharmaceuticals (Letall)
Form: Tablet
Packaging Size: 3 Strips of 10 Tablets (Total: 30 Tablets)
Packaging Type: Strip
Prescription Required: Yes
Country of Origin: Made in India
Minimum Order Quantity: 10 Strips
Each tablet contains: Letrozole 2.5 mg
Indication: Treatment of breast cancer in postmenopausal women
Specifically used for:
Early-stage hormone receptor-positive breast cancer
Metastatic breast cancer
As adjuvant therapy following surgery or radiation treatment
Letrozole is a non-steroidal aromatase inhibitor that works by reducing estrogen levels in the body, which helps slow or stop the growth of hormone-sensitive breast cancer cells.
Taken orally, once daily, with or without food
Dosage and treatment duration should be determined by a qualified oncologist
Regular monitoring is essential during treatment
Clinically proven efficacy in hormone-receptor-positive breast cancer
Manufactured by leading pharmaceutical companies Cipla and Intas Pharmaceuticals
Convenient strip packaging ensures proper dosing and storage
Suitable for clinical and hospital settings
Cost-effective alternative to international brands